Cancer Clues Gleaned from Somatic Mutation Patterns in Normal Bladders
With targeted, exome, and whole-genome sequencing data, investigators saw recurrent driver mutations and heterogeneous mutational signatures in seemingly normal bladders.
Oslo University Hospital Researchers Use Arrays to ID Markers for Colorectal, Bladder Cancers
By Justin Petrone A team of researchers at Oslo University Hospital has used arrays and other technologies to identify several gene signatures and biomarkers that could be used to diagnose and treat a number of cancers.
Taris is the latest MIT spinout to attract significant VC cash after receiving early-stage proof-of-concept funding from the school's Deshpande Center, further highlighting the center's ability to speed commercialization of MIT biomedical research.